Renalytix announces the launch of its Clinical Advisory Board. The Clinical Advisory Board members include: Stephen Brunton; Matthew Jay Budoff; Barry I. Freedman; Ralph A. DeFronzo; Holly J. Mattix-Kramer; Javier Morales; Joseph A. Vassalotti; Eugene E. Wright Jr.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RNLX:
- Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
- Renalytix enters Middle East distribution agreement with Vector Pharma
- Renalytix Announces Middle East Distribution Agreement with Vector Pharma
- Renalytix management to meet virtually with BTIG
- Renalytix announces clinical data on KidneyIntelX in vitro prognostic use